Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2012
12/06/2012WO2012166706A2 Supramolecular nanofibers and hydrogels based on oligopeptides functionalized with nucleobases
12/06/2012WO2012166390A1 Neprilysin inhibitors
12/06/2012WO2012165648A1 Cyclohexanone compounds and herbicides comprising the same
12/06/2012WO2012165398A1 Cycloalkyloxybiaryl compound
12/06/2012WO2012164582A1 Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[ 1, 2-a]-pyrimidin-4-one (paliperidone) and paliperidone palmitate.
12/06/2012WO2012162818A1 Substituted diarylamines and use of same as antioxidants
12/06/2012US20120309777 Substituted 2-imidazolidones and analogs
12/06/2012US20120309759 Screening Method and Compounds for Modulating Telomerase Activity
12/06/2012US20120309705 Novel 3'-deoxy-3'-methylidene-beta-l-nucleosides
12/06/2012CA2837227A1 Novel immune system modulators
12/06/2012CA2835609A1 Cyclohexanone compounds and herbicides comprising the same
12/06/2012CA2835220A1 Neprilysin inhibitors
12/05/2012EP2528903A1 5-alkynyl-pyrimidines
12/05/2012EP2528890A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators
12/05/2012EP2528606A1 Quinazoline-based t cell proliferation inhibitors
12/05/2012CN1989111B Method for the production of 3-phenyl(thio)uracils and dithiouracils
12/05/2012CN102812019A Process and intermediates for preparing lapatinib
12/05/2012CN102807558A Fluorine-containing dihydroindene amide compound used as protein kinase inhibitor
12/05/2012CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
12/05/2012CN102807530A Process for preparing amorphous rosuvastatin calcium free of impurities
12/05/2012CN101801928B Novel cyclo-dione herbicides
12/05/2012CN101602733B Diaryl pyridine derivatives, preparation method thereof and application thereof
12/05/2012CN101565404B Heterocyclic compounds
12/05/2012CN101516858B Crystalline antifungal compounds
12/04/2012US8324383 Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
12/04/2012US8324245 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/04/2012US8324233 Co-crystals of pyrimethanil and dithianon
12/04/2012US8324230 Kinase inhibitor; amtiinflammatory agents; rheumatic diseases; osteoarthritis; asthma
12/04/2012US8324229 Alkylthio pyrimidines as CRTH2 antagonists
12/04/2012US8324221 Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
12/04/2012US8324220 Pyrimidines useful as modulators of voltage-gated ion channels
12/04/2012US8324208 Prolyl hydroxylase inhibitors
12/04/2012US8324205 Quinazoline derivatives as kinase inhibitors
12/04/2012US8324186 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2
12/04/2012CA2518932C 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/2012
11/29/2012WO2012159662A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
11/29/2012WO2012159457A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
11/29/2012WO2012159456A1 Cdc42 inhibitor and uses thereof
11/29/2012US20120302749 Processes for the preparation of erlotinib hydrochloride form a and erlotinib hydrochloride form b
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/28/2012EP2527331A1 Process for the preparation of substituted cynophenoxy-pyrimidinyloxy-phenyl acrylate derivatives
11/28/2012EP2527330A1 Inhibitors of the hedgehog pathway
11/28/2012EP2526093A2 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
11/28/2012CN102803227A Morpholinylquinazolines
11/28/2012CN102803216A Heterocyclic antiviral compounds
11/28/2012CN102803212A Heterocyclic Antiviral Compound
11/28/2012CN102796081A Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/28/2012CN102796050A Cdc42 inhibitor and application thereof
11/28/2012CN102796049A Method for preparing bensulfuron methyl
11/28/2012CN102795953A Method for synthesizing caffeic acid amide derivative by using caffeic acid and sulfanilamide drug as raw materials and application
11/28/2012CN102079728B Tripolycyanamide analogue, preparation method of tripolycyanamide analogue and intermediate used in preparation method
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/27/2012US8318975 Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof
11/27/2012US8318934 Process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes
11/27/2012US8318933 Process for preparing rosuvastatin calcium
11/27/2012US8318932 Process for producing 4-aminoquinazoline compound
11/27/2012US8318758 5-fluoro-2-oxopyrimidine-1(2H)-carboxylate derivatives
11/27/2012US8318755 Inhibitors of SYK and JAK protein kinases
11/27/2012US8318749 Quinazoline derivatives as NK3 receptor antagonists
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318736 HIV inhibiting 5,6-substituted pyrimidines
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012CA2525214C Macrocyclic quinazoline derivatives as antiproliferative agents
11/27/2012CA2487805C Peptide deformylase inhibitors
11/22/2012WO2012156498A1 Quinazoline derivatives for the treatment of viral infections and further diseases
11/22/2012WO2012156467A1 Novel pkc inhibitors
11/22/2012WO2012156221A1 Process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoyl-amino)benzyl]pyrimidin-5-yl]acetic acid
11/22/2012WO2012155806A1 4-aminoquinazoline derivatives and uses thereof
11/22/2012WO2012155516A1 Aggregation-inducing luminescent penta-substituted tetrahydropyrimidine and use thereof
11/22/2012WO2012155339A1 4-phenylamino-6-butenamide-7-alkyloxy quinazoline derivatives, preparative method and use thereof
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012US20120295928 Methods for detecting and reducing impurities of lapatinib and salts thereof
11/22/2012US20120295923 Aminocyclohexanes and Aminotetrahydropyrans and Related Compounds As Gamma-Secretase Modulators
11/22/2012US20120295911 Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
11/22/2012US20120295907 Insecticidal compounds
11/22/2012US20120295874 Coferons and methods of making and using them
11/22/2012US20120294835 Substituted pyridines and pyrimidines
11/22/2012CA2836311A1 Amine derivatives as potassium channel blockers
11/22/2012CA2835229A1 Quinazoline derivatives for the treatment of viral infections and further diseases
11/21/2012CN102792162A Method for prediabetes screening
11/21/2012CN102791705A Inverse agonists and neutral antagonists for the TSH receptor
11/21/2012CN102791697A Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
11/21/2012CN102791659A Materials for electronic devices
11/21/2012CN102786497A Preparation method of piperazine compound and intermediate thereof
11/21/2012CN102786483A Medicinal use of 4-(4-phenylpiperazino)quinazoline derivatives
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102786481A Novel erlotinib derivative
11/21/2012CN102786480A 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3- alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides
11/21/2012CN102786479A Preparation method of 4-hydroxy-substituted pyrimidine compound
11/21/2012CN101973943B Preparation method of (E)-2-[2-(6-pyrimidine-4-yloxy) phenyl]-3-methoxyacrylate
11/21/2012CN101906053B 酰胺衍生物 Amide derivatives
11/21/2012CN101838267B Triazole compound and preparation and application thereof
11/20/2012US8314116 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
11/20/2012US8314115 Method of treating movement disorders using barbituric acid derivatives
11/20/2012US8314110 Compounds for treating mental disorders, and preparation and uses thereof
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/20/2012US8314087 Nitrogen-containing heterocyclyl ketones and methods of use
11/15/2012WO2012154249A1 Substituted aminobutyric derivatives as neprilysin inhibitors
11/15/2012WO2012152644A1 Production of dense bodies (db) from hcmv-infected cells
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 427